Identification of driver genes for critical forms of COVID-19 in a deeply phenotyped young patient cohort
Raphaël Carapito(Inserm), Anne Thomas(Stragen (France)), Géraldine Laumond(Inserm), Sabrina Bibi‐Triki(Inserm), Sharvari Gujja(Gynuity Health Projects), Julien Pottecher(Fédération Hospitalo-Universitaire, Paris Center for Microbiome Medicine), Paul Bastard(Inserm), Richard Y. Li(GeneFluidics (United States)), Leslie Muller(Centre National de la Recherche Scientifique), Sylvain Mayeur(Université de Lille), Ouria Tahar(Fédération Hospitalo-Universitaire, Paris Center for Microbiome Medicine), M. Javad Aman(National Heart Lung and Blood Institute), Michael Simons(Yale University), Julie Helms(Inserm), Tristan Stemmelen(Inserm), Adrian Gervais(Inserm), Thiên‐Nga Chamaraux‐Tran(Yale University), Véronique Rolli(Inserm), Razieh Mohseninia(University of Southern California), Elisa Pin(KTH Royal Institute of Technology), Bernard Goichot(Fédération Hospitalo-Universitaire, Paris Center for Microbiome Medicine), Cécile Macquin(Inserm), Maleka Schenck(Fédération Hospitalo-Universitaire, Paris Center for Microbiome Medicine), Perrine Spinnhirny(Inserm), Angélique Pichot(Inserm), Qian Zhang(Cixian People's Hospital), Aurélie Hirschler(Centre National de la Recherche Scientifique), Antoine Hanauer(Inserm), Xavier Mariette(Inserm), Sylvie Schmidt(Inserm), Paul‐Michel Mertès(Université de Strasbourg), Julia Frappier(Inserm), Khaldoun Kuteifan(Groupe Hospitalier de la Région de Mulhouse et Sud Alsace), Olivier Hermine(Centre National de la Recherche Scientifique), Yvon Ruch(Hôpitaux Universitaires de Strasbourg), Anne Molitor(Inserm), Bernard Drénou(Groupe Hospitalier de la Région de Mulhouse et Sud Alsace), Jose Malagon-Lopez(GeneFluidics (United States)), Alexandre Lederle(Inserm), Raony Guimaraes(GeneFluidics (United States)), Peter Nilsson(Science for Life Laboratory), Christine Carapito(Centre National de la Recherche Scientifique), Nicodème Paul(Inserm), François Danion(Hôpitaux Universitaires de Strasbourg), Samira Fafi‐Kremer(Centre National de la Recherche Scientifique), Olivier Collange(Fédération Hospitalo-Universitaire, Paris Center for Microbiome Medicine), Haiguo Wu(GeneFluidics (United States)), Shweta Kailasan(Integrated BioTherapeutics (United States)), Alice Bernard(University of Tübingen), Annabel Larnicol(Inserm)
Cited by 125
Related Papers
A framework for human microbiome research
|Nature|2012|2.8k
CIRCLE-seq: a highly sensitive in vitro screen for genome-wide CRISPR–Cas9 nuclease off-targets
|Nature Methods|2017|831